Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

Autor: Ruzsa, A., Sen, M., Evans, M., Lee, L., Hideghety, K., Rottey, S., Klimak, P., Holeckova, P., Fayette, J., Csoszi, T., Erfan, J., Forssmann, U., Goddemeier, T., Bexon, A., Nutting, C.
Zdroj: Investigational New Drugs; Dec2014, Vol. 32 Issue 6, p1278-1284, 7p
Databáze: Complementary Index
Externí odkaz: